All posts by imreal

Coterie Advisors Expands Executive Leadership Team


News Image

Combined with his professional experience and long-term industry relationships, Mike Lambert will be an asset to our partnership team and will drive our Affordability-Based Medical Plan strategy to elevate our market success.

Coterie Advisory Group Inc., whose founding partners include some of the original founders of Star HRG (Starbridge®) and Ternian® Insurance Group, have announced that Mike Lambert, formerly of Axis Insurance Company® and AIG®, will be joining Coterie Advisor’s executive leadership team as: Partner and Executive Vice President of National Sales.

Mike will head their strategic development efforts with employee benefits Brokers and Consultants to focus on Coterie Advisor’s Fundamental Care® product set. Their Limited Benefit Indemnity plans allow employers to offer affordable and unique health insurance options for their uninsured, part-time, and hourly workers which provides coverage for basic medical expenses. It complements Coterie Advisor’s flagship product, their level-funded Limited Day Health Plan, which offers near-comprehensive coverage at 30-40% less than the cost of traditional high-deductible health plans. With their combined proprietary products, Coterie Advisors offers an Affordability-Based Medical Plan strategy that is unique to the marketplace.

Aaron Cook, President of Coterie Advisors said, “Our founding partners are excited to announce that Mike Lambert is joining our team as a Partner in Coterie Advisors. Mike is a strategic thinker who has a track-record and successful career in the group limited medical marketplace. Cook added, “Combined with his professional experience and long-term industry relationships, he will be an asset to our partnership team and will drive our Affordability-Based Medical Plan strategy to elevate our market success.”

The affordability void in healthcare continues to be a major issue in the United States. With over 28 Million uninsured and 70% of workers living paycheck to paycheck, Coterie Advisors continues to manufacture solutions that meet the needs of the underserved. Fundamental Care provides access to unique and affordable insurance benefits on a guarantee issue basis. Limited Day and Limited Benefit Indemnity plans can be customized and structured with affordable premiums and no deductibles. The plans are high in potential coverage and include upfront, day-one benefits – healthcare employees can actually use. Both plans meet the employer’s ACA mandated requirement for offering Minimum Essential Coverage.

Coterie Advisors believes they are well-positioned to meet the “new normal” of marketplace needs based on the changes that will result from the current economic environment. For more information, please contact your employee benefits broker or visit http://www.fundamentalcare.com or http://www.coterieadvisors.com.

###

Aaron Cook

President & Co-Founder

aaron.cook@coterieadvisors.com

ABOUT COTERIE ADVISORS:

Coterie Advisory Group, Inc. is a Scottsdale-based, insurance program manager and consultative advisor who delivers Affordability-Based Medical Plan Strategies to help benefit brokers, employers, and associations in the benefits industry. Since 1990, the founding partners of Coterie Advisors have specialized in Affordability-Based Medical Plans. They have decades of experience working with some of the nation’s largest service industry employers and understand the unique needs of a variable hour workforce made up of part-time, hourly, and seasonal employees. Their unique and proprietary Affordability-Based Medical Plans (Fundamental Care) include fully-insured limited-benefit indemnity plans and level-funded limited-day plans which solve real-world problems, make a meaningful difference in consumers’ lives, and have a track record of being market-leading and market-changing.

Share article on social media or email:

TPx Communications Appoints Don Joos as Chief Executive Officer


Don Joos, TPx Communications

Don Joos, Chief Executive Officer, TPx Communications

“Don … is well-suited to drive TPx’s strategic and operational transformation and further its mission of delivering superior managed IT solutions.”

TPx Communications, the premier managed services provider, announced today that its Board of Directors has named Don Joos, a proven leader with more than 20 years of experience in the technology industry, as Chief Executive Officer, effective immediately. Mr. Joos succeeds Joe Cozzolino, who has served as interim CEO during the board’s search for a CEO. Mr. Cozzolino will continue to serve as Executive Chairman of the Board of TPx.

Mr. Joos brings to TPx a deep industry knowledge and a strong track record of transforming high-tech companies. Most recently, he served as the CEO of PGi, the world’s largest dedicated provider of collaboration software and services, and, like TPx, a portfolio company of Siris Capital Group LLC (“Siris”). Prior to joining PGi in 2017, Joos served as President and CEO of ShoreTel, driving the strategic transformation of the business from a pure hardware solution into one of the leading cloud communications providers.

Mr. Cozzolino said, “Don has an excellent track record of driving change, performance and results in high-growth, innovative technology companies, and is well-suited to drive TPx’s strategic and operational transformation and further its mission of delivering superior managed IT solutions. As Executive Chairman, I look forward to working closely with Don to help the team achieve its strategic objectives.”

Mr. Joos stated, “I am honored to be appointed to this role during an exciting time at TPx. My focus will be on accelerating TPx’s development, building on its industry-leading customer satisfaction, tremendous range of award-winning products, and its large, diversified customer base. TPx plays an important role in serving the fast-growing addressable market for UCaaS, CCaaS and managed IT services, including security, and is aligned to expand market share. I look forward to partnering with TPx’s leadership team and employees to drive the company’s next phase of transformation.”

About TPx

Founded in 1998, TPx is a leading provider of UCaaS, Managed IT services and Managed Connectivity services, with approximately 25,000 customers with more than 50,000 customer locations across the U.S. TPx has best-in-class customer service embedded in its corporate DNA, offering guaranteed performance to all customers wherever there’s a broadband connection. TPx customers serve every business sector and include many government and not-for-profit enterprises. For more information, visit http://www.tpx.com or follow @TPxComm on Twitter.

About Siris

Siris is a leading private equity firm that invests primarily in technology and telecommunications companies with mission-critical products and services. Its investment approach is based on a combination of proprietary research and extensive collaboration with senior operating executives, who actively participate in key aspects of the transaction lifecycle to help drive strategic and operational value. Siris is based in New York and Silicon Valley and has raised nearly $6 billion in cumulative capital commitments. http://www.siris.com    

Share article on social media or email:

Telehealth, Remote Patient Monitoring Crucial to Long-Term Cardiac Health Implications of COVID-19


Remote patient monitoring

“Although we’re still learning about COVID-19, it’s transformed our healthcare system’s monitoring and treatment approaches for patients,” InfoBionic CEO Stuart Long said.

As concerns grow over the long-term cardiovascular health implications of COVID-19, health providers look to remote patient monitoring and telehealth to improve patient outcomes. Leading ambulatory cardiac monitoring provider InfoBionic sees a tremendous challenge ahead where thousands will deal with long-term cardiovascular health effects of COVID-19. “Although we’re still learning about COVID-19, it’s transformed our healthcare system’s monitoring and treatment approaches for patients,” InfoBionic CEO Stuart Long said. With cardiovascular injury a long-term effect for COVID-19 survivors, healthcare needs a proven means of telemetry style remote cardiac monitoring that can facilitate faster interventions that can improve health outcomes.”

Studies have shown that up to 20 percent of patients with COVID-19 may have heart injury due to coronavirus, which researchers attribute to inflammation from infection.(1) This comes at a time when a small but increasing number of cases in the US and elsewhere show that otherwise healthy people with coronavirus are suffering blood vessel injuries, blood clots, arrhythmia, strokes, and heart attacks due to excessive clotting.(2)

COVID-19 Causes, Hotspots and the Heart

A growing understanding among researchers and cardiologists is that the coronavirus appears to enter and infect the heart cells though ACE2 receptors. These receptors are prevalent in the lungs, the heart and blood vessels where the virus can lead to cell dysfunction and cellular death.(3) Current inflammation drugs used to treat the infection can also exacerbate underlying heart issues.(4)

While the most recent data shows that 20 states are classified as hotspots (i.e. increasing infection rates), healthcare must simultaneously deal with the long-term health implications of COVID-19 survivors.(5) There is a growing prevalence of reports showing the lasting heart impairments of the coronavirus and how persistent inflammation can cause chronic cardiac complications after recovery.(6)(7)

There is a new understanding of the cardiovascular dangers for young as well as older patients with and without comorbidities. These long-term health risks positions remote patient monitoring (RPM) to impact everything from sick leave and disability policies to research studies on the long-term effects of a COVID-19 aftermath.(8)

The understanding of COVID-19 and the long-term health effects of survivors and what they might need in terms of healthcare is still being studied.(9) but it’s already clear that a significant portion of the more than 2.5 million Americans who’ve contracted coronavirus may have lingering symptoms. This can be seen in the mounting stories of those who have survived COVID-19 but face ongoing health challenges, with many being heart-related conditions.(10)

Heart Monitoring and Long-term COVID Heart Health

COVID-19 complications connected to heart health may emerge and disappear. Healthcare providers will need ways to monitor the cardiovascular health of these patients remotely to curb hospital readmissions and circumvent heart issues before they become serious according to Long.

Remote cardiac monitoring and telehealth are obvious solutions to this problem as telehealth and RPM use for recovering COVID-19 patients becomes more prevalent.(11) The new reality of RPM and telehealth can be seen in the following surveys:

  • 88 percent of healthcare providers have invested in, or are evaluating, RPM technologies.(12)
  • A survey of HR executives showed that 77 percent of respondents saw telehealth as a permanent change regardless of the length of the pandemic.(13)

The reality is that monitoring a significant post-COVID-19 patient population in the long term will be a reality that requires health providers, cardiologists, and hospitals to have solutions that are simple and unobtrusive for the patient. According to Long, the implications of RPM are far reaching beyond the countless conditions associated with inflammation impacting heart health. “A major need for effective RPM will include studies impacting longer health outcomes and treatments of these conditions,” Long explained. Physicians and cardiologists will need non-invasive cardiac monitors that provide full disclosure data to deal effectively with these needs without disrupting patient lives.”

The evolution of these monitoring interventions and studies will require healthcare providers and researchers to continuously review user experience, adoption rates and resulting outcomes. This will impact future interventions, treatments and understanding of how viruses generally and COVID-19 specifically impact the body long-term. The recent update of legislation from the Food and Drug Administration allowing usage modifications in the function of RPM tools during the COVID-19 Outbreak will go a long way to changing the dynamic of long-term health outcomes.(14)

About InfoBionic:

InfoBionic is a digital health company transforming the efficiency and economics of ambulatory remote patient monitoring processes by optimizing clinical and real-world utility for the users that need it most—physicians and their patients. The Massachusetts-based team of seasoned entrepreneurs leverages successful careers in healthcare, IT, medical devices, and mobile technology, along with specific expertise in remote monitoring and cardiology. Their first-hand experience with the complexities of traditional cardiac arrhythmia detection and monitoring processes led to design of the transformative MoMe® Kardia platform to remove the roadblocks, thus amounting to a faster and more effective process for decision-making and diagnosis. InfoBionic is the recipient of the Frost & Sullivan 2019 North American Remote Cardiac Monitoring Technology Leadership Award. For more information, visit http://www.infobionic.com.

1.    Shi S, Qin M, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China, JAMA Cardiology, March 25, 2020, jamanetwork.com/journals/jamacardiology/fullarticle/2763524.

2.    Katherine Harmon Courage. “Coronavirus’s new mystery: It’s causing strokes in healthy people,” Vox, May 1, 2020, vox.com/2020/5/1/21244171/stroke-coronavirus-symptoms-blood-clots

3.    Julia Reis. “COVID-19 Can Attack the Heart in Addition to the Lungs,” Healthline, May 20, 2020, healthline.com/health-news/how-covid-19-triggers-heart-conditions

4.    Lun Wang, Yang Zhang, Shuyang Zhang. “Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy,” Frontiers in Cardiovascular Medicine, April 30, 2020. frontiersin.org/articles/10.3389/fcvm.2020.00078/full

5.    Jennifer Kates, et al. “Where are the COVID-19 Hotspots? Tracking State Outbreaks,” Kaiser Family Foundation, June 24, 2020, kff.org/coronavirus-covid-19/issue-brief/where-are-the-covid-19-hotspots-tracking-state-outbreaks/

6.    Brit Long William J. Brady, Alex Koyfman Michael Gottlieb. “Cardiovascular complications in COVID-19,” American Journal of Emergency Medicine, April 14, 2020, ajemjournal.com/action/showPdf?pii=S0735-6757%2820%2930277-1

7.    Akbarshakh Akhmerov, Eduardo Marbán. COVID-19 and the Heart, AHA Journals circulation research, April 3, 2020, ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.120.317055

8.    Lisa Du. “Virus Survivors Could Suffer Severe Health Effects for Years,” Blomberg, May 12, 2020, bloomberg.com/news/articles/2020-05-12/covid-19-s-health-effects-can-last-long-after-virus-is-gone

9.    Lois Parshley. The emerging long-term complications of Covid-19, explained,” Voc, June 12, 2020, vox.com/2020/5/8/21251899/coronavirus-long-term-effects-symptoms

10.    Rick Jervis, Lindsay Schnell, Alan Gomez, and Deborah Barfield Berry. “Memory loss, gnarled fingers, panic attacks: COVID-19 didn’t kill these Americans, but many might never be the same,” USA Today, June 19, 2020, usatoday.com/in-depth/news/nation/2020/05/29/coronavirus-survivors-battle-ongoing-symptoms-might-never-same/5215914002/

11.    Kevin Joy. “How Remote Patient Monitoring Is Aiding the COVID-19 Fight,” HealthTech Magazine, June 11, 2020, healthtechmagazine.net/article/2020/06/how-remote-patient-monitoring-aiding-covid-19-fight-perfcon

12.    Samantha McGrail. “88% of Providers Investing in Remote Patient Monitoring Tech,” mHealth Intelligence, November 4, 2019, mhealthintelligence.com/news/88-of-providers-investing-in-remote-patient-monitoring-tech

13.    Rafi Musher, Mark Bremer, et al. “Forecasting the long-term impact of telemedicine,” Stax, April 20, 2020, stax.com/telemed

14.    Coronavirus (COVID-19) Update: FDA allows expanded use of devices to monitor patients’ vital signs remotely, FDA, March 20, 2020, fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-allows-expanded-use-devices-monitor-patients-vital-signs-remotely

# # #

BIA Welcomes Julie Jury as Senior Litigation Technology Expert


Julie Jury, BIA

“Julie’s two and a half decades specializing in eDiscovery and legal technology have given her extensive experience in multiple review platforms. These platforms are complex and constantly changing, so it’s important that users have guidance from a top-tier specialist.”

BIA, a national eDiscovery and digital forensic services provider, today announced the addition of Julie Jury as senior litigation technology expert.

For nearly 30 years, Jury has used her astute understanding of legal technology in multiple complex global projects. Most recently, she worked as the director of project management at AmerAsia Law, LLC, where she acted as liaison between clients, partners and key stakeholders to meet eDiscovery project requirements and timeframes. Prior to that she spent eight years as a senior project and product consultant at Catalyst Repository Systems, where she consulted with corporate clients regarding eDiscovery, data processing, creation of Catalyst review sites, document review strategies and more. Jury also spent 18 years as a litigation support specialist and a paralegal.

“Julie’s two and a half decades specializing in eDiscovery and legal technology have given her extensive experience in multiple review platforms,” said Lisa Prowse, SVP of legal services and document review at BIA. “These platforms are complex and constantly changing, so it’s important that users have guidance from a top-tier specialist. We’re happy to offer that expertise to our clients.”

In her new role, Jury will provide her knowledge to BIA clients and internal teams by consulting on best practices, training on the Relativity platform and its add-ons, and analyzing multiple data sources to identify and resolve issues. She will also oversee the execution of reviews in Relativity by assisting in-house review attorneys, clients and outside counsel; providing support for eDiscovery technical tasks; performing quality control of processed data; ensuring the accuracy of data loading, manipulation and conversion; and more.

“Here at BIA we pride ourselves in using various eDiscovery processes and technologies to best support our clients,” said BIA President and CEO Brian Schrader. “The years Julie spent on complex global cases consulting in eDiscovery best practices, data processing, document review strategies and production have made her an expert in litigation technology and project management. We’re excited to further provide in-depth knowledge of Relativity and other review platforms to all BIA clients.”

ABOUT BIA

As an industry pioneer, BIA continues to set the standard for reliable, innovative and cost-effective eDiscovery services. Its customer-first focus has resulted in countless innovations copied widely across the industry today. From technical innovations like truly remote data collections and the first cloud-based, end-to-end eDiscovery platform to service revolutions like reusing data and coding across matters and hiring dedicated, full-time employees for document review, BIA consistently stands at the leading edge of the industry. Founded by legal and technology professionals, BIA provides the entire spectrum of eDiscovery services – including attorney document review – with minimal disruption to its clients’ daily business operations. To learn more, visit BIA at http://www.biaprotect.com or on Twitter at @biaprotect.

Share article on social media or email:



FAA Selects Team to Create UTM Contingency Management Platform at Griffiss International Airport


A long-endurance drone flies a mission near the Adirondack mountains. NUAIR, (Northeast UAS Airspace Integration Research) is developing a BVLOS test site near Rome, NY.  [illustration by Kongsberg Geospatial]

A long-endurance drone flies a mission near the Adirondack mountains. NUAIR is developing a BVLOS test site near Rome, NY. [illustration by Kongsberg Geospatial]

We’re excited to work directly with the FAA to bring together some of the most innovative companies in the industry to tackle operational safety in UTM.

Kongsberg Geospatial, an Ottawa-based aerospace and defense geospatial technology company, announced that it has been selected as part of the team responsible for developing and testing a new integrated Contingency Management Platform (CMP) at the New York Unmanned Aircraft Systems (UAS) Test Site, at Griffiss International Airport in Rome, NY.

The Federal Aviation Administration (FAA) recently awarded a $1.6M contract that will advance unmanned traffic management (UTM) at the New York (NY) Unmanned Aircraft Systems (UAS) Test Site, at Griffiss International Airport. The project will be developed by a team of five commercial companies, led by CAL Analytics, of Beavercreek, OH.

The team will be developing a single, integrated Contingency Management Platform for unmanned aircraft integration. Together with NUAIR, (Northeast UAS Airspace Integration Research) and Oneida County, the team will integrate and test their CMP technology to address specific safety and risk mitigation concerns for operating UAS in the national airspace the NY UAS Test Site.

Complex integrated systems, like unmanned traffic management, rely on a multitude of data from various sources to make decisions – often with real-world safety implications. The Contingency Management Platform will offer important protection protocols and situational awareness, alerting operators of faults, failures, and severe weather to help ensure the safe flight of all unmanned aircraft.

System integration for the final product will be led by CAL Analytics. ResilienX, of Syracuse, NY will be providing health monitoring and fault mitigation software. Cybersecurity components will be provided by Assured Information Security (AIS) of Rome, NY. TruWeather of Syracuse, NY will be providing micro-weather services. Kongsberg Geospatial, of Ottawa, Canada, will be providing beyond visual line-of-sight (BVLOS) airspace visualization capabilities for the CMP.

“We’re excited to work directly with the FAA to bring together some of the most innovative companies in the industry to tackle operational safety in UTM,” said Dr. Sean Calhoun, Managing Director of CAL Analytics. “Validating a contingency management approach is a critical, but often overlooked, step to achieve routine commercial drone operations.”

Validation testing will be managed by NUAIR who manages operations at the Oneida County-owned New York UAS Test Site at Griffiss International Airport in Rome, NY; one of just seven FAA-designated UAS test sites in the United States. The team will also leverage the state’s 50-mile UAS Corridor, which is equipped with radars and advanced technologies to facilitate advanced drone operations.

“This partnership further solidifies Oneida County’s UAS Test Site as the global leader in industry research and advancement,” said Oneida County Executive Anthony J. Picente Jr. “The unmanned traffic management corridor we have been establishing from Rome to Syracuse is laying the groundwork for the future of UAS deployment, performance, safety and delivery capabilities.”

Kongsberg Geospatial will be deploying IRIS UxS – a real-time airspace visualization system for beyond visual line-of-sight (BVLOS) mission management that allows a single operator to manage multiple aircraft. The system is built on the company’s TerraLens real-time geospatial engine, and combines real-time data from a variety of sensors to create a real-time picture of the airspace where UAS are being operated.

“For the past few years, we’ve been working on improving safety for BVLOS UAS missions through the development of IRIS UxS,” explains Kongsberg vice president, Paige Cutland. “The IRIS system is now actively deployed for a variety of long-range mission applications including drone delivery, pipeline inspection, and emergency airspace operations.”

“Having a reliable UTM health and monitoring function is a key element in the safe integration and commercialization of unmanned aircraft,” said Andy Thurling, chief technology officer at NUAIR. “CAL, ResilienX, and TruWeather continue to be integral partners of NUAIR and the New York UAS Test Site, and we look forward to advancing routine, commercial UAS operations utilizing this program.”

Andrew Carter, President and CTO of ResilienX said, “Performance Authorizations, identified in v2 of the FAA’s UTM CONOPS will lead to scalable, routine commercial drone operations, a goal of the UAS corridor in New York. ResilienX is providing safety assurance though health monitoring and fault mitigation software to maintain a safe level of performance through encountered faults, failures or adverse conditions, enabling these complex ecosystems.”

TruWeather Solutions will deploy its dynamic platform that collects and presents real-time, predictive micro-weather analytics and insights. “TruWeather is excited to build and demonstrate our weather hazard notification services,” said CEO, Don Berchoff. “The CMP will monitor our scalable and agile TruFliteTM alert service to notify UTM providers and operators of emerging adverse conditions to alert specific drone types to take evasive action. The power of the service is other drones, not similarly impacted by the conditions, can continue flying.”

“AIS is thrilled to be a part of this FAA sponsored program in ensuring the cybersecurity of UTM, as a predicate for safe routine operations of UAS in the national air space,” said Scott Robidoux, chief operating officer at AIS. “AIS is leveraging its industry leading capabilities to provide the necessary cybersecurity performance monitoring of the UTM as part of its overall health and integrity.”

The contract is part of the FAA’s efforts to perform vital drone integration safety work at the FAA’s federally-designated UAS test sites. The project was awarded after a competitive acquisition process and intended for “qualified companies who can work at FAA UAS testing sites to forward essential integration technologies such as sense and avoid capabilities, geofencing, and unmanned traffic management (UTM.)”

The Contingency Management Platform is expected to be deployed and tested over the next few months.

ENDS ###

About Kongsberg Geospatial: Based in Ottawa, Canada, Kongsberg Geospatial (https://kongsberggeospatial.com) creates precision real-time software for air traffic control and UxS and situational awareness. The Company’s products are primarily deployed in solutions for air-traffic control, Command and Control, and air defense. Over nearly three decades of providing dependable performance under extreme conditions, Kongsberg Geospatial has become the leading geospatial technology provider for mission-critical applications where lives are on the line. Kongsberg Geospatial is a subsidiary of Kongsberg Defence Systems.

Media contact: 1-800-267-2626 or reach us by email at info@kongsberggeospatial.com

About CAL Analytics: CAL Analytics (calanalytics.com) is a small business focusing on the development of aviation and autonomous systems. Located in Dayton, OH and founded in 2010, CAL Analytics has expertise in navigation systems, remote sensing, signal analysis, and information fusion. Their mission is to provide agile and rigorous R&D to bring new technologies to the world.

About ResilienX: ResilienX (resilienx.com) is pioneering safety in UAS Traffic Management. Through automatic fault detection, fault isolation and contingency management, the company provides the equivalent to a “check engine light” for the Unmanned Traffic Management ecosystem. ResilienX software increases system robustness and operational up-time; moving UTM out of the lab and into the real world.

About AIS: Assured Information Security, or AIS (ainfosec.com) provides government and commercial customers with industry leading cyber and information security capabilities specializing in research, development, consulting, testing, forensics, remediation and training. The company envisions their clients, their customers and their nation’s citizens being able to safely operate and conduct business with efficiency and confidence.

About TruWeather: Founded by US Air Force veterans, TruWeather (truweathersolutions.com) has developed a weather risk mitigation framework to serve weather sensitive businesses and industries in the private sector to increase safety and productivity when weather is a potential threat to business operations.

About NUAIR: Northeast UAS Airspace Integration Research, or NUAIR (nuair.org) is a New York based nonprofit organization that provides unsurpassed expertise in Unmanned Aircraft Systems (UAS) operations, aeronautical research, and safety management. Headquartered in Syracuse, NUAIR manages operations of the New York UAS Test Site at Griffiss International Airport in Rome, NY and developing New York’s 50-Mile UAS Corridor.

NeoTract Designates Dr. Tim Davenport as UroLift® Center of Excellence


News Image

“This designation recognizes Dr. Tim Davenport as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Tim Davenport, M.D., The Jackson Clinic in Jackson, TN, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Davenport has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Tim Davenport as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Wellbeing ‘energy practice’, Access Bars, holds live online session to combat isolation blues


With social distancing measures still being enforced in many parts of the world, many people are finding they are unable to partake in their usual wellbeing and personal development practices.

In fact, an early draft of a study by researchers at The University of Manchester and Swansea University has shown that social distancing has had severely negative results on the mental health of the UK population, and American experts have spoken out to confirm they expect the situation to be the same in the US.

Researcher Simon Williams said the study found “…emotional ‘losses,’ such as a loss of self-worth, loss of motivation and a loss of meaning in daily life.”

In an effort to make mental wellbeing practices available to those ready and willing to receive it, Access Bars® will be running an online Bars session with facilitator, author and speaker Brendon Watt on July 9, with thousands of virtual attendees expected to join via Zoom.

“We know that this ‘subtle energy’ practice has the ability to completely transform a person’s state of mind, and we want to make it easily accessible for those looking for relief during this time. Normally, these sessions are conducted in person by a trained facilitator, but in light of the COVID-19 crisis, we have shifted to make it possible to still receive the benefits of the practice online,” says Brendon Watt.

Access Bars® is a set of 32 points on the head which, when lightly touched, stimulate positive change in the brain, body and psyche. Developed thirty years ago by speaker and consciousness pioneer, Gary Douglas, this subtle energy practice has been rapidly gaining popularity with celebrities, elite athletes and health-seekers all over the world, due to its accessibility and gentle approach.

According to Dr. Terrie Hope PhD, DNM, CFMW, in a study published in the Journal of Energy Psychology: Theory, Research, and Treatment in November 2017, the results of one 90-minute Access Bars® session indicated a significant decrease in the severity of depression and anxiety.

Tickets for the online class are available via the Access Consciousness website (http://www.accessconsciousness.com).

About Brendon Watt

Brendon Watt is an author, speaker, entrepreneur, and life mentor. He is one of the lead facilitators of Access Consciousness®, a set of simple-yet-profound tools currently transforming lives in 176 countries. Drawing upon his transformation from a struggling tradesman and single dad to global speaker, Brendon facilitates classes and workshops all over the world empowering others to know they are not wrong, that anything is possible and that they are only one choice away from change.

Share article on social media or email:

Rigaku Analytical Devices to present during Thai Industrial Pharmacist Association (TIPA) Webinar


Rigaku Progeny handheld Raman analyzer

Rigaku Progeny handheld Raman analyzer

Thai Industrial Pharmacist Association (TIPA), founded in September 2011, is a non-profit organization representing members from the pharmaceutical / biopharmaceutical industry, regulatory agencies, academia and service providers.

Rigaku Analytical Devices, the market leader in handheld 1064nm Raman technology, will present its solution for raw material identification during a webinar hosted by the Thai Industrial Pharmacist Association (TIPA) on July 16, 2020 at 9:30am ICT / 8:30pm EDT. Crest Nanosolution Limited, a local partner of Rigaku located in Thailand, has been instrumental in setting up this event.

Thai Industrial Pharmacist Association (TIPA), founded in September 2011, is a non-profit organization representing members from the pharmaceutical / biopharmaceutical industry, regulatory agencies, academia and service providers. TIPA is also accredited from the Pharmacy Council of Thailand as an institution for continuing pharmaceutical education. TIPA plays a very important role in the field of industrial pharmacy and pharmaceutical science in Thailand by organizing various local and international conferences to promote the exchange of knowledge and research in industrial pharmacy and related fields. The association also works closely with other associations in the region and around the world.

In the session titled, “Application of Handheld Raman for Raw Material Identification and Verification,” Jill Carreiro, Global Pharmaceutical Business Development Director at Rigaku Analytical Devices, will present an overview of the role of handheld Raman spectroscopy in the pharmaceutical market and how the needs and regulations of the industry have changed globally. In addition, the implementation of the Rigaku Progeny handheld 1064nm Raman analyzer for raw material identification, at-line, and finished product quality testing will be discussed.

Pharmacists will earn 1 CPE credit for participating.

About the Rigaku Progeny 1064nm Handheld Raman Analyzer

The Progeny handheld Raman offers the proven robustness required for high-throughput raw materials testing while being uniquely versatile enough to provide the scientific answers needed for more experimental applications. Its use of 1064nm Raman spectroscopy provides less fluorescence issues that traditional handheld Raman spectrometers are susceptible to with the added benefit of scanning through packaging. This means an increase in the speed of analysis, expanded number of materials that can be measured, and improved selectivity for greater confidence.

Additional smart features available include:

  • Ergonomically angled display with large touchscreen buttons for single-hand operation
  • Built in camera / barcode scanner
  • Adjustable focus nose cone to measure through thick polymer or dark glass
  • IP-68 sealed system to minimize cross-contamination
  • Intuitive touchscreen user interface
  • Full control of analysis parameters
  • High-speed multi-function processor and on-board memory
  • Automated data backup process for confident audit trail and data integrity
  • Connect to PC/server path via USB or WiFi
  • 100% permanent file of data resides on tool
  • 21 CFR compliant firmware and sync software

The Progeny analyzer is supported by the Rigaku global sales and support distribution team, offering 24//7 Reachback support, library updates and software upgrades for the life of the analyzer.

To register for this TIPA webinar, please visit http://www.tipa.or.th. For more information on the Rigaku Progeny 1064nm handheld analyzer, please visit http://www.rigaku.com/Progeny

About Rigaku Analytical Devices

Rigaku Analytical Devices is leading with innovation to pioneer a portfolio of handheld and portable spectroscopic analyzers for use in public health and safety, scientific and academic study, recycling and reuse of metal alloys, and to ensure the quality of key metal alloy components in critical industries. We strive to deliver quality, reliability and engaged expertise to our customers with our advanced product and capabilities and are dedicated to continual product development efforts to deliver mission critical enhancements to performance and functionality and reliable, cost-effective solutions for end users. Our rugged products operate on an open architecture platform and deliver unparalleled accuracy and support for rapid lab-quality results any time, any place.

For further information, contact:

Jen Lynch

Marketing Director

Rigaku Analytical Devices

Wilmington, MA USA

Tel: +1 781-328-1024

Jen.Lynch@rigaku.com

Share article on social media or email:

Trident at AIU Professor’s COVID-19 Mitigation Plan Achieves Positive Results


Dr. Paul Persaud, Faculty, Trident

For a virus without a vaccine, contact tracing is one of the most effective ways to deter its spread. The importance of contact tracers during the outbreak of a communicable disease cannot be overstated. – Dr. Paul Persaud.

Dr. Thakur “Paul” Persaud, a part-time faculty member in Trident at American InterContinental University’s (Trident) College of Health and Human Services, has led a proactive charge against the spread of COVID-19 as the Director of Public Health in the City of Paterson, NJ.

His leadership has helped to mitigate the spread of the virus, with Paterson’s death rate among those who have tested positive for coronavirus sitting below the state average. The New York Times and National Public Radio, among others, have taken notice of his strategy.

While there is still much to achieve, these promising results can be traced back to Dr. Persaud’s foresight. Last year the city’s infectious disease staff sat at two. Convinced of the need of expansion and additional training in order to combat communicable diseases, Dr. Persaud successfully lobbied Paterson’s mayor for a $95,000 state grant.

Today the city’s COVID Contact Tracing Team sits at 55 people, most of them performing the time-intensive, yet essential role of contact tracing. This has put Paterson ahead of its neighbors, including the nearby New York City.

“For a virus without a vaccine, contact tracing is one of the most effective ways to deter its spread,” states Dr. Persaud. “The importance of contact tracers during the outbreak of a communicable disease cannot be overstated.”

Contact tracing is the process of identifying anyone who may have come into contact with an infection person. Tracers will collect information about these individuals, test them for the virus, help the potentially infected get treated, and then in turn, identify additional people who came into contact with these additional individuals.

Dr. Persaud has been a faculty member at Trident since 2010, teaching Emergency Healthcare Logistics in Disasters, Homeland Recovery and Continuity of Operations, and Survey of Emergency and Disaster Management.

He earned a Ph.D. in Public Health, with an Epidemiology concentration, from Walden University and a Master of Public Health from Columbia University.

About Trident at American InterContinental University

Founded in 1998, Trident at American InterContinental University (Trident at AIU) is part of an online postsecondary university serving adult learners. Trident at AIU uses the EdActive™ learning approach, which employs case-based learning in an online setting to teach real-world relevant critical thinking skills designed to enhance the lives and education of students. Trident offers quality associate, bachelor’s, master’s, and doctoral degree programs and certificates, led by a qualified faculty team, over 80% of whom have doctoral degrees. Trident at AIU is regionally accredited by the Higher Learning Commission (hlcommission.org) and has more than 22,000 alumni with a military affiliation. Trident has received acknowledgements from Washington Monthly, Military Times, and Military Advanced Education & Transition for their dedication to student success. Visit http://www.trident.edu or call at (855) 290-0290 to learn more about Trident at AIU’s wide range of educational options.

Share article on social media or email:

U.S. Dermatology Partners, is pleased to welcome Kyle Kaltwasser, MD to their Baytown and Clear Lake offices


Board Certified Houston Dermatologist Dr. Kyle Kaltwasser

Kyle Kaltwasser, MD

“Kyle has strong academic interests in skin cancer mimickers, vasculitis, and rashes from immune modulators. He is a frequent presenter at Texas Dermatologic Society meetings,” said Aaron Joseph, MD, Fellowship Trained Mohs Surgeon, U.S. Dermatology Partners South Texas Region.

U.S. Dermatology Partners is excited to welcome Board-Certified Dermatologist Kyle Kaltwasser, MD to its Baytown and Clear Lake office

Dr. Kyle Kaltwasser grew up in nearby Deer Park, Texas before attending Texas A&M University where he obtained a Bachelor of Science degree in biology in 2010. He then completed his medical degree in 2015 at the University of Texas Medical Branch in Galveston where he was elected into the Alpha Omega Alpha and Gold Humanism honor societies.

Dr. Kaltwasser began his medical internship at the Houston Methodist Hospital located in the Texas Medical Center. He went on to complete his dermatology residency at the University of Texas Medical Branch in 2019. He is an active member of the Texas Dermatological Society and the American Academy of Dermatology.

Dr. Kaltwasser is married to his high school sweetheart and they have two golden retrievers. He is an avid Houston Rockets and Texas A&M football sports fan. In his free time, he enjoys traveling with his wife, staying active, reading, and cooking.

Kaltwasser will be working in our Baytown and Clear Lake offices with Drs. Chang and Williams and Kendra McCarty, P.A. “Kyle has strong academic interests in skin cancer mimickers, vasculitis, and rashes from immune modulators. He is a frequent presenter at Texas Dermatologic Society meetings,” said Aaron Joseph, MD, Fellowship Trained Mohs Surgeon for U.S. Dermatology Partners South Texas Region.

Bay Area Dermatology Associates, now U.S. Dermatology Partners was founded by Dr. Terry Williams in 1976. He was joined in 1998 by Dr. Janice Chang. The practice focus is on medical dermatology and surgical dermatology, but some select cosmetic dermatology services are provided as well. The group has provided knowledgeable and consistent dermatological care to the Clear Lake and Galveston Bay areas for more than 40 years. Contact us to schedule an appointment today with one of our board-certified dermatologists at any of our four convenient locations: Baytown, Clear Lake, Texas City, or Webster.

For more information or to schedule a new appointment, please contact the office at 832-695-3112.

About U.S. Dermatology Partners

As one of the largest physician-owned dermatology practices in the country, U.S. Dermatology Partners’ patients have access to general medical, surgical, and cosmetic skin treatments through its coordinated care network, and also benefit from the practice’s strong dermatology subspecialty thought leaders and medical advisory board. To be the best partner to its patients, U.S. Dermatology Partners is fervently focused on providing the highest level of patient-first care, and its team, therefore, includes recognized national leaders in areas such as clinical research, psoriasis, and Mohs Surgery. To learn more, visit usdermatologypartners.com.

Share article on social media or email: